Early Phase 1 trials of an HIV vaccine have started, Moderna announced Thursday. The vaccine under development uses mRNA, or messenger RNA, to provoke an immune response.
The trials will be taking place at Hope Clinic of Emory Vaccine Center in Atlanta, Fred Hutchinson Cancer Research Center in Seattle and the University of Texas-Health Science Center at San Antonio.
There is currently no cure for HIV, the virus that causes AIDS, though people who have it can control it with treatments,Vaccines using mRNA help prime the immune system against targeted viruses and are currently being used in the fight against COVID-19 pandemic.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Moderna launches clinical trial for HIV vaccine that uses mRNA technology
Lire la suite »
Moderna launches clinical trial for HIV vaccine that uses mRNA technologyModerna announced Thursday that it's launched early-stage clinical trials of an HIV mRNA vaccine. The biotechnology company has teamed up with the nonprofit International AIDS Vaccine Initiative to develop the shot, which uses the same technology as Moderna's successful COVID-19 vaccine. The first participants in the Phase I trial were given doses at George Washington University School of Medicine and Health Sciences in Washington, D.C., according to a company statement.
Lire la suite »
Moderna Launches Clinical Trials for HIV VaccineHuman clinical trials have started for an experimental HIV vaccine that uses the same kind of mRNA technology found in Moderna’s successful COVID-19 vaccine, the drug company announced this week.
Lire la suite »
Moderna begins human trials for HIV vaccineModerna has launched early-stage human trials for an mRNA vaccine to treat HIV, the company announced to investors on Thursday.
Lire la suite »
Study Finds Cancer Drug May Also Flush Out Dormant HIVPart of the reason HIV is so hard to cure is that it hides in a state of hibernation inside long-lived immune cells.
Lire la suite »
Moderna begins human trials for HIV vaccineModerna has launched early-stage human trials for an mRNA vaccine to treat HIV, the company announced to investors on Thursday.
Lire la suite »